Treatment Costs in Canada of Health Conditions Resulting From Chronic Hepatitis B Infection

Abstract

The cost of treating Canadian subjects with hepatitis B-related conditions increases substantially with deteriorating liver function. Any new therapy that proves to be more effective at slowing or preventing the course of liver disease progression would be cost-effective.